Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Keli Walbert

Keli Walbert is recorded as Board Member at Hemab Therapeutics Holdings, Inc. (COAG). Hemab Therapeutics Holdings, Inc. reported in an 8-K filed September 24, 2026 that Keli Walbert was appointed member of the Board, effective September 24, 2026.

“On September 24, 2026, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Hemab Therapeutics Holdings, Inc. (the "Company"), the Board elected Keli Walbert to serve as a member of the Board, effective immediately.”
Hemab Therapeutics Holdings, Inc. Form 8-K, filed September 24, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.